Search Results
Results found for "Kelsey Person"
- đź“° GPCR Weekly News, May 8 to 14, 2023
Binders, Drugs, and more In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
gpcr-binders-drugs-and-more/in-depth-molecular-profiling-of-an-intronic-gnao1-mutant-as-the-basis-for-personalized-high-throughput-drug-screening
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Precision medicines for GPCRs: AI can facilitate the development of personalized treatments by analyzing
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
This can guide the development of more personalised therapies tailored to the genetic makeup of individual
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
Personalised Medicine Another significant application of these findings is in personalised  medicine This personalised approach could optimise drug efficacy while minimising adverse effects, improving treatment Conclusion In summary, the findings of this study have significant implications for drug design, personalised
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Perrone, M. G.; Brea, J.; Loza, M. I.; Infantino, V.; Abate, C.; Contino, M.
